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PR-mediated Gag processingOur goal was to determine the contribution of HIV-1 reverse transcriptase tryptophan repeat motif residues
to virion maturation. With the exception of W402A, we found none of the single substitution mutations
exerted major impacts on virus assembly or processing. However, all mutants except for W410A exhibited
signiﬁcant decreases in virus-associated RT, presumably a result of unstable RT mutant degradation. Muta-
tions W398A, W401A and W406A decreased the enhancement effect of efavirenz on PR-mediated Gag pro-
cessing efﬁciency, which is in agreement with their destabilizing RT effects. Furthermore, combined double
or triple W398, W401 and W406 mutations signiﬁcantly affected virus processing and Gag–Pol packaging.
Further analyses suggest that inefﬁcient PR-mediated Gag cleavage partly accounts for the virion processing
defect. Our results support the idea that in addition to playing a role in RT heterodimer stabilization, the RT
Trp repeat motif in the Gag–Pol context is also involved in PR activation via Gag–Pol/Gag–Pol interaction.
© 2011 Elsevier Inc. All rights reserved.Introduction
TheHIV-1 pol gene encodes three enzymes that are essential to virus
replication: protease (PR), reverse transcriptase (RT), and integrase
(IN) (Ratner et al., 1985). The partial pol overlap with the Gag viral
structure protein coding sequence is translated as a Pr160gag–pol poly-
peptide resulting from ribosomal frameshifting (Jacks et al., 1988).
Pr55 Gag precursor molecules undergo multimerization and form
virus particles (Swanstrom and Wills, 1997). It is generally believed
that Pr160gag–pol is incorporated into virions via interaction with
Pr55gag (Chien et al., 2006; Chiu et al., 2002; Halwani et al., 2003;
Huang and Martin, 1997; Smith et al., 1993; Srinivasakumar et al.,
1995). During or soon after virus budding, Pr55gag is cleaved by PR
into four major products: p17 (matrix, or MA), p24 (capsid, or CA), p7
(nucleocapsid, or NC), and p6. In addition to Gag cleavage products,
Pr160gag–pol cleavage produces PR, RT and IN (Swanstrom and Wills,
1997). This PR-mediated virus particle maturation process is necessary
to acquire viral infectivity (Gottlinger et al., 1989; Kohl et al., 1988; Peng
et al., 1989).
How PR is activated to mediate virus maturation is not completely
clear. It is assumed that Gag–Pol dimerization or multimerization trig-
gers PR activation, after which PR functions as a homodimer cleaved
fromGag–Pol, aswell as amediator of further Gag andGag–Pol cleavage
(Swanstrom and Wills, 1997). Accordingly, the inability of Gag–Polarch and Education, Taipei Vet-
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rights reserved.mutants to either autoprocess or trans process Pr55gagmay be attribut-
ed to a defect in Gag–Pol/Gag–Pol interaction. In support of this as-
sumption, defective Gag cleavage has been found in HIV-1 mutants
that have deletions involving sequences upstream or downstream of
the PR domain (Bukovsky and Gottlinger, 1996; Chiu et al., 2002; Liao
and Wang, 2004; Quillent et al., 1996; Zybarth and Carter, 1995).
RT that is located adjacent to the C-terminus of PR expresses its
enzymatic activity as a p66/p51 heterodimer (di Marzo Veronese et
al., 1986; Lightfoote et al., 1986), therefore the possibility exists that
an RT sequence within Gag–Pol may contribute to PR activation by fa-
voring Gag–Pol/Gag–Pol interaction via RT–RT interaction. This hy-
pothesis is supported by the ﬁnding that efavirenz (EFV), a non-
nucleoside reverse transcriptase inhibitor (NNRTI) that enhances RT
dimerization in vitro (Tachedjian et al., 2005; Tachedjian et al.,
2001; Venezia et al., 2006), reduces virus production as a result of
greatly enhanced Gag and Gag–Pol cleavage (Figueiredo et al., 2006;
Tachedjian et al., 2005). It is assumed that increased polyprotein pro-
cessing efﬁciency results from the premature activation of PR by EFV-
enhanced Gag–Pol multimerization via the embedded RT sequence. In
contrast, a RT mutation with an alanine substitution for residue
W401, which results in impaired dimerization as well as signiﬁcantly
impaired RT stability (Mulky et al., 2005; Tachedjian et al., 2003;
Wapling et al., 2005), counteracts the enhancement effect of EFV on
Gag processing in a similar manner as the EFV-resistant mutant
L100I/K103N (Chiang et al., 2009). This supports the idea that RT mu-
tations that affect RT–RT interaction also cause defects in Gag–Pol/
Gag–Pol interaction that impede the EFV enhancement of Gag–Pol
multimerization, consequently decreasing the EFV enhancement of
Gag processing.
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the connection subdomain of the HIV-1 RT subunit (codons
398–414) has been identiﬁed (Baillon et al., 1991). This Trp repeat
motif is highly conserved among primate lentiviral reverse transcrip-
tases. In addition to substitutions W401A and W401L, changes in
W414 residues to leucine also disrupt in vitro RT dimerization
(Tachedjian et al., 2003), suggesting a role for the Trp repeat motif
in RT–RT interaction. The Trp repeat motif likely plays a role in mod-
ulating PR activation by inﬂuencing Gag–Pol/Gag–Pol interaction.
This hypothesis is supported by our previous ﬁnding that W402 re-
placement with alanine or leucine results in enhanced Pr55gag cleav-
age, leading to a signiﬁcant reduction in virion release (Chiang et al.,
2010). Although results from co-immunoprecipitation experiments
and yeast two-hybrid studies indicate that substitution mutations at
W398, W402, Y405, W406 or W410 do not signiﬁcantly affect RT di-
merization (Tachedjian et al., 2003), it remains to be seen whether
these mutations destabilize virion-associated RT, or exert any inﬂu-
ence on PR-mediated Gag processing.
For this study we extended our previous research to determine
whether substitutions at other Trp repeat motif residues affect virus
assembly and processing. Speciﬁcally, we used EFV to determine the
effects of substitution mutations on Gag–Pol/Gag–Pol interaction, as-
suming that RT mutations might counteract the EFV enhancement of
Gag processing if they affect Gag–Pol/Gag–Pol interaction. We found
that in addition to W401A, both W398A andW406A conferred partial
resistance to the enhancement effect of EFV on Gag processing, de-
spite the lack of detectable effects on steady-state Gag processing in
the absence of EFV. Combined double or triple substitutions among
residues W398, W401 and W406 or the removal of the Trp repeat
motif resulted in signiﬁcant defects in both Gag processing and
Gag–Pol packaging. Our data support the proposal that the HIV-1 RT
Trp repeat motif plays an important role in determining PR activation
by stabilizing Gag–Pol/Gag–Pol interaction.
Results
With the exception of W402A, all alanine substitution mutants are
assembly-competent and express a wild-type Gag processing proﬁle
To analyze the effects of Trp repeat motif residue replacement on
virus particle assembly in the presence or absence of EFV, we intro-
duced alanine substitutions at W398, W401, W406, W410 or W414.
In addition, alanine was also substituted for the highly conserved
Y405 (Fig. 1A). For a control we used the EFV-resistant mutant
L100I/K103N (Bacheler et al., 2000), which is insensitive to the EFV
enhancement effect on Gag processing (Chiang et al., 2009). The
HIV-1 RT dimerization-defective mutations L234A (Ghosh et al.,
1996; Tachedjian et al., 2000; Wohrl et al., 1997) and L289K (Goel
et al., 1993) were also inserted. Our assumption was that the twomu-
tations would negate the EFV enhancement of Gag cleavage in a man-
ner similar to that of the RT dimerization-defective mutant W401A
(Mulky et al., 2005; Tachedjian et al., 2003; Wapling et al., 2005).
Each construct was transiently expressed in 293 T cells, and virus par-
ticle assembly and processing were analyzed by Western immuno-
blotting. Our results indicate that all of the mutants were assembly-
competent and exhibited a wt virus particle processing proﬁle. The
one exception was W402A, whose virion production was markedly
reduced; this result is consistent with previous reports (Chiang et
al., 2010). However, except for W410A (which possesses substantial
amounts of virus-associated p66/51RT), all mutants had markedly re-
duced RT quantities compared to the wt virion (Fig. 1B). Similar re-
sults were observed in repeat independent experiments. Our ability
to detect virus-associated IN suggests that RT deﬁciency in most of
the mutants was likely due, at least in part, to RT instability. However,
we cannot exclude the possibility that these mutations also exerted
an effect on Gag–Pol stability, since IN levels in L234A, L289K,W398A and W406 virions were signiﬁcantly reduced compared to
wt. Alternatively and/or additionally, RT and IN deﬁciency may be
the result of a defect in Gag–Pol incorporation. Thus, it is not surpris-
ing that most of the mutants are noninfectious or poorly infectious. In
addition, their virus-associated RT levels and/or RT instability have
signiﬁcant correlations with their in vitro RT activity (Table 1).W398A and W406A are associated with reduced sensitivity to the EFV
enhancement effect on Gag processing
As shown in Fig. 2A, wt virion production was signiﬁcantly re-
duced by EFV. However, consistent with previous results, W401A
and L100I/K103N virion assembly and processing were not signiﬁ-
cantly affected by EFV (Chiang et al., 2009). In contrast, signiﬁcant re-
ductions in virion production were noted for Y405A, W410A and
W414A, in a manner similar to EFV-treated wt virions. As expected,
EFV did not signiﬁcantly affect L234A and L289K virion production.
Virion quantities produced byW398A orW406A were moderately re-
duced when treated with 1 μM EFV; wt virion production was mark-
edly suppressed at this dosage (data not shown). This suggests that
both W398A and W406A are capable of partially counteracting the
enhancement effect of EFV on Gag processing in a manner similar to
the double mutant W401/W402A (Chiang et al., 2009). Alternatively
or additionally, EFV may rescue (at least in part) the degradation of
HIV Gag and its processing products in mutant virions.
Strong correlations were noted between the mutants L234A,
L289K, W401A, W401/402A, W389A and W406A (all insensitive to
the inhibitory effect of EFV on virus production) and RT instability
or dimerization defects, suggesting that impaired RT–RT interaction
may contribute, at least in part, to counteracting the EFV enhance-
ment effect on Gag processing by impeding EFV-enhanced Gag–Pol
multimerization. In support of this assumption, W401A and W401L
(both defective in RT dimerization) (Wapling et al., 2005) counter-
acted the EFV enhancement effect on Gag processing, whereas
W401F (both RT-stable and RT dimerization-competent) (Wapling
et al., 2005) expressed markedly reduced virion production following
EFV treatment (data not shown).
The combination of W398A and W406A mutations, as well as the
deletion of the Trp repeat motif codons 398–414 (ΔTRM), both
resulted in signiﬁcant Gag cleavage impairment, with Pr55gag and
p41gag representing the major Gag species in both supernatant and
cellular samples (Fig. 2B, lanes 9 and 11). In three independent exper-
iments, W398/406A and ΔTRM exhibited respective four-fold to ﬁve-
fold and double to three-fold increases in virus-associated Pr55gag/
p24gag ratios compared to the wt, suggesting that the mutants were
signiﬁcantly defective in virus maturation.
To determine whether mutants with or without noticeably defec-
tive virus processing had morphologies that differed from the wt, we
observed virus pellets containing wt, W398A, W406, W398/406A or
ΔTRM particles using a transmission electron microscope. Wild-type
particles exhibited cylindrical or cone-shaped electron-dense cores
that are characteristic of mature virus morphology (Figs. 3A and B).
Instead of conical electron-dense cores, most of the RT mutant
cores were either asymmetrical and/or electron-lucent compared
to those of the wt (Fig. 3C–J). W406A particles were heterologous
in terms of size, with a signiﬁcant percentage of observed particles
being larger than the wt. Immature cores with crescent-shaped
electron-dense rings were observed in many W398/406A and
ΔTRM particles (Figs. 3H and J). Although both W398A and W406A
displayed a virus particle processing pattern similar to that of the
wt, they did not exhibit mature particle morphology (Figs. 3C–F vs.
Figs. 3A and B). These data suggest that the RT mutations caused a
defect in virus maturation, but under some circumstances the defect
is barely detectable by Western immunoblot analyses of mutant
virions.
Fig. 1. Effects of amino acid substitutions in HIV-1 RT on virus assembly and processing. (A) Schematic representations of HIV-1-encoded Gag and Gag–Pol polyproteins. Mature Gag
protein domains and pol-encoded p6*, PR, RT, and IN (p31) are indicated, along with p66RT subdomain boundaries. Indicated is the Trp repeat motif from codons 398 to 414 in the
RT connection subdomain. Conserved Trp residues are in bold type, and a conserved Tyr residue at codon 405 is underlined. The backbone of all expression constructs is HIVgpt. (B)
293 T cells were transfected with designated constructs. At 48–72 h post-transfection, cells and culture supernatant were collected and prepared for Western immunoblot analysis.
Cells (4% of total sample) and viral pellets (50% of total sample) were fractionated by 10% SDS-PAGE and electroblotted onto nitrocellulose ﬁlters. HIV-1 Gag proteins were probed
with an anti-p24CA monoclonal antibody. RT and IN were detected with anti-RT and anti-IN serum. Positions of Pr160gag–pol, RT p66 and p51 subunits, IN, Pr55gag, p41gag, and p24gag
are indicated.
Table 1
Relative reverse transcriptase activity and infectivity levels of HIV-1 mutants.
Constructs RT activity (%)±SD Infectivity (%)±SD
WT 100 100
W398A 5±2 0
W401A 5±2 5±2
W402A 25±5 6±3
Y405A 77 24±7
W406A 0 0
W410A 116±18 40±7
W414A 44±4 24±5
293 T cells were transfected with the indicated plasmid plus a VSV-G expression vec-
tor. At 48–72 h post-transfection, approximately 50% of the collected supernatant
was were pelted and subjected toWestern immunoblot analysis and in vitro RT activity
assay. The remaining supernatants were aliquoted and used to infect HeLa cells. Infec-
tion and selection of drug-resistant colonies were performed as described in Methods.
Drug-resistant colonies were converted to titers (c.f.u./ml). No drug-resistant colonies
were detected in the absence of VSV-G co-expression (data not shown). Wild-type
(HIVgpt) titers were determined in parallel experiments. Experiments were performed
in triplicate. Ratios of RT activity and viral titers to Gag protein levels (obtained via im-
munoblot band density quantiﬁcation) were determined for each mutant and normal-
ized to those of wt in parallel experiments. Mean and standard deviation (M±SD)
values are indicated.
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Pol packaging
The W398/406A Gag processing defect shown in Fig. 2 may be the
result of insufﬁcient Gag–Pol incorporation. Another possibility is that
the Gag–Pol mutant may be incapable of supporting the Gag–Pol/
Gag–Pol interaction required for full PR activation. These potential ex-
planations are not mutually exclusive. Although a point RT mutation
may exert little or no effect on Gag–Pol/Gag–Pol interaction, it is like-
ly that any combination of mutations that disrupt RT stability or di-
merization will also exert a signiﬁcant effect on Gag–Pol/Gag–Pol
interaction, consequently impairing PR-mediated Gag cleavage. To
test this idea, we constructed double or triple mutants by recombin-
ing the putatively unstable RT mutants W398A, W401A and W406A,
yielding W398/401A, W401/406A and W398/401/406A in addition
to W398/406A. Compared to the wt virion, all mutants demonstrated
increased ratios of Pr55gag to p24gag, indicating a virus processing de-
fect (Fig. 4A). In addition, virus-associated RT was degraded or barely
detectable. When PR activity was partially inhibited by an HIV-1 PR
inhibitor, virus-associated RT was detectable in both W398/401A
andW401/406A virions (Fig. 4B), suggesting that their RT deﬁciencies
were due, at least in part, to the PR-mediated degradation of unstable
RT mutants. However, neither W398/406A nor W398/401/406A
Fig. 2. Effect of efavirenz on HIV-1 RT mutant assembly and processing. 293 T cells were transfected with designated constructs. At 18 h post-transfection, transfectants were split
equally onto two plates and either mock-treated or treated with 5 μM efavirenz (EFV). At 4 h, culture supernatant was removed and replaced with medium containing the indicated
chemicals. At 48 h post-medium replacement, cells and supernatant were harvested for Western immunoblot analysis. Representative blots from three independent experiments
are shown.
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levels following the inhibition of PR activity (Fig. 4B, lanes 7–10), sug-
gesting a severe defect in Gag–Pol incorporation into virions.
Gag–Pol mutants that are defective in Pr55gag association may be
cleaved by PR prior to being packaged into virions, resulting in mark-
edly reduced Gag–Pol packaging. To mitigate the impact of PR activity
on Gag–Pol packaging, we assessed virion assembly when PR activity
was almost completely blocked by a high dose of the PR inhibitor.
According to our results, both W398A and W406A had virus-
associated Gag–Pol levels comparable to that of the wt virion
(Fig. 5A) following the complete inhibition of PR activity. In contrast,
W401/406A, W398/406A, W398/401/406A and ΔTRM all showed sig-
niﬁcant decreases in Gag–Pol packaging compared to the wt virion.
W398/401A exhibited a relatively lower level of virus-associated
Gag–Pol, but the reduction was not statistically signiﬁcant.
Since residual PR activity (that is, activity that is not completely
blocked by a PR inhibitor) may reduce Gag–Pol packaging, weperformed tests to determine if W398/406A and W398/401/406A
still exhibited signiﬁcantly defective Gag–Pol packaging in a PR-
inactivated (PR-) expression vector. In one set of experiments,
W398/406A, ΔTRM, and the wt were individually introduced into a
PR-inactivated HIV-1 Pr160gag–pol expression plasmid GPfs, with gag
and pol in the same reading frame (Chiu et al., 2002); each resulting
construct was co-expressed with Pr55gag. Our results indicate that
W398/406A and W398/401/406A contained quantities of virus-
associated Pr160gag–pol that were between 20% and 40% that of the
wt (Fig. 5C, lanes 1–6). When Pr160gag–pol and Pr55gag were separate-
ly expressed in co-transfected plasmids, virus-associated Pr160gag–pol
packaging efﬁciency in both W398/406A and ΔTRM were between
10% and 20% that of the wt (Fig. 5C, lanes 7–12); these results are
similar to those for the PR inhibitor treatment. Combined, these
data suggest that mutations at the Trp repeat motif signiﬁcantly affect
Gag–Pol packaging, which may contribute to impaired virus
processing.
Fig. 3. Virus particle morphology. Culture supernatants from transfected 293 T cells
were collected and ﬁltered through 20% sucrose cushions. Pellets were resuspended
in PBS buffer, stained, and observed with a TEM. Images represent the phenotypes of
50–70% of observed particles. Panels A and B, wild-type; C and D, W398A; E and F,
W406A; G and H, W398/406A; I and J, ΔTRM. Bars, 100 nm.
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In addition to decreased Gag–Pol packaging, suppressed PR activ-
ity is detrimental to virus maturation. As shown in the upper panels
of Fig. 4B, lanes 8 and 10, W398/406A and W398/401/406A Gag pro-
cessing was signiﬁcantly suppressed following the same PR inhibitor
treatment that exerted moderate effects on wt, W398/401A, and
W401/406A Gag processing, which suggests impaired PR-mediated
Gag processing. We observed many instances of double or triple mu-
tants, with ΔTRM in particular showing a higher ratio of cellular
Pr55gag to p24gag compared to that found in wt cell lysates (Fig. 4A,
top panel).
Since cell samples were collected between 48 and 72 h post-
transfection, the possibility exists that Gag processing had reached a
level of stability that prevented us from detecting a difference in efﬁ-
ciency between the wt form and mutants. To test this possibility, as
well as to conﬁrm that Trp repeat motif mutations affected Gag pro-
cessing efﬁciency, we collected cell samples at different time points
following the transient expression of wt and mutants. W402A (as-
sembly-defective as a result of enhanced Gag processing) was used
as a control. Assays were performed for the substitution mutants
W398A, W401A and W406A, since they exhibited RT instability and
either partly or completely negated the EFV enhancement effect on
Gag processing. As shown in Fig. 6, W402A showed a Gag processing
efﬁciency level at least threefold that of the wt at 16 h post-
transfection. This ﬁnding agrees with previously reported data indi-
cating that the W402A assembly defect is a result of enhanced Gag
cleavage efﬁciency (Chiang et al., 2010).
As expected, W398/406A and ΔTRM Gag processing efﬁciency was
between 25% and 50% that of the wt at 16–24 h post-transfection. ForW401A the ﬁgure was approximately 30% of wt processing efﬁciency
at 16 h post-transfection, even though it displayed a wt steady-state
Gag processing proﬁle. In contrast, enhanced Gag processing efﬁcien-
cy was observed for W398A andW406A, with the latter approximate-
ly twofold greater than the wt at 16–24 h. We observed signiﬁcantly
reduced W406A virion release compared to the wt (Fig. 2A, lane
15), perhaps associated with enhanced Gag processing; otherwise,
the increased efﬁciency did not signiﬁcantly affect virion assembly.
Combined, the data suggest that the Trp repeat motif mutations
markedly impacted PR-mediated Gag processing, likely via their ef-
fects on Gag–Pol/Gag–Pol interaction.
Discussion
Our data indicate that an alanine substitution at HIV-1 RT W402,
W398 or W406 results in medium-to-strong enhancement of Gag
processing efﬁciency, and that a double W398/406A mutation or the
deletion of the Trp repeat motif signiﬁcantly impairs PR-mediated
Gag processing. The virus-processing defect of the double and triple
mutations is attributable in part to insufﬁcient Gag–Pol packaging.
However, we believe that impaired virus processing is largely due
to impaired PR activation, given that a minimum amount of PR is suf-
ﬁcient in terms of enzymatic activity to process Gag particles (Chen et
al., 2004). According to our results, the Trp repeat motif is involved in
modulating PR activation, likely by promoting proper (i.e., not prema-
ture) Gag–Pol/Gag–Pol interaction.
With the exception of W410A, all single substitution mutants in
the Trp repeat motif expressed poor RT activity (Table 1), which
agrees with their virus-associated p66/51RT deﬁciency. Although
W410A contains substantial amounts of RT and IN and shows near-
wt RT activity, results from a single cycle infection assay indicate
that its infectivity was reduced to one-half that of the wild type
(Table 1). This reconﬁrms the critical role of the RT Trp repeat motif
in HIV-1 replication.
Past results from yeast two-hybrid screens for RT dimerization
and in vitro binding assays indicate mutations at W401 and W414,
both in the context of p66RT subunit abrogate RT heterodimerization
(Tachedjian et al., 2003). In addition, infectious virion assay results
show that residues W398, W401, W402, Y405, W406 and W414 me-
diate RT subunit interactions (Mulky et al., 2005). Accordingly, re-
duced or barely detectable p66/51RT in W398A, Y405A, and W414A
virions is likely due to a defect in RT dimerization, with a consequence
of unstable RT dimers being susceptible to PR cleavage. This assump-
tion is also supported by deﬁciencies of normal virus-associated
p66/51RT in W401A, L289K, and other RT thumb subdomain mutants
resulting from the PR-mediated cleavage of unstable RT mutants
(Dunn et al., 2009). Also compatible with this hypothesis, a PR muta-
tion partially compensates for a mutation that destabilizes RT
(Olivares et al., 2007). Further support comes from our consistent ob-
servation that barely detectable p66/51RT in W398/401A and
W401/406A virions became readily detectable when PR activity was
inhibited (Fig. 4B). Decreases in virus-associated IN and RT in double
or triple mutants were likely due, at least in part, to inefﬁcient Gag–
Pol packaging, similar to descriptions of HIV-1 RT substitutions at co-
dons G190 (Huang et al., 2003) and L234 (Buxton et al., 2005; Yu et
al., 1998). It is also possible that premature W398A and W406A
Gag–Pol cleavage contributes to decreases in virus-associated RT
and IN, since both demonstrated enhanced PR-mediated Gag proces-
sing efﬁciency (Fig. 6).
Given that PR activation is triggered by Gag–Pol/Gag–Pol interac-
tion, a RT point mutation may not affect Gag–Pol/Gag–Pol interaction
to the degree that it impairs PR activation, even though the mutation
signiﬁcantly disrupts RT–RT interaction or destabilizes RT dimeriza-
tion. For instance, W414A and W414L both demonstrated a wt
steady-stage Gag processing proﬁle and were sensitive to an EFV en-
hancement effect on Gag processing, despite having impaired RT
Fig. 4. RT mutations signiﬁcantly affected virus maturation and RT stability. 293 T cells were transfected with wt or mutant HIVgpt plasmids containing the designated double or
triple substitution mutations, or a deletion of the Trp repeat motif (ΔTRM). (Panel B) At 4 h post-transfection, cells were replated onto two dish plates and either left untreated, or
treated with the HIV-1 protease inhibitor (PI) Ro31-8959. At 48 to 72 h post-transfection, cells and culture supernatants were collected, prepared, and subjected to Western im-
munoblot analysis. Positions of Pr160gag–pol, RT p66 and p51 subunits, p31IN, Pr55gag, p41gag, and p24gag are indicated. The ratio of virus-associated Pr55gag to p24gag was deter-
mined for each mutant and normalized to that of wt in parallel (Panel A).
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EFV enhancement of Gag processing are also strongly associated
with RT instability. Reduced mutant sensitivity to EFV suggests that
the RT mutations may have affected Gag–Pol conformation or Gag–
Pol/Gag–Pol interaction in a manner that prevents EFV binding or
that disables bound EFV, thus decreasing Gag–Pol multimerization.
These data suggest that under some circumstances, EFV can serve as
a probe for determining whether a RT mutation impacts Gag–Pol/
Gag–Pol interaction. A possible explanation for W414A/L sensitivity
to EFV is that the mutations do not markedly affect Gag–Pol/Gag–
Pol interaction, even though they signiﬁcantly impair RT stability.
Both the ΔTRM and double W398/406A mutations signiﬁcantly
impaired PR-mediated virus maturation and caused a signiﬁcant
delay in Gag cleavage. This implies a defect in full PR activation, pre-
sumably due, at least in part, to inadequate Gag–Pol/Gag–Pol interac-
tion. However, impaired Gag–Pol/Gag–Pol interaction does not
appear to signiﬁcantly compromise Gag–Pol multimerization: results
from velocity sedimentation analyses indicate that mutant Pr160gag–pol
molecules are still capable of multimerization into complexes
with high molecular weights—that is, they primarily sedimented at
the same sucrose density fractions as wt Pr160gag–pol (data not
shown). This is not surprising, since N-terminal Gag (which contains
major assembly domains) may be dominant in determining Gag–Pol
multimerization status.
Trp repeat motif mutations may induce a conformational change in
Gag–Pol that in turn disrupts Gag–Pol/Gag–Pol interaction, ultimately
resulting in premature or inefﬁcient PR activation. Furthermore, Gag–Pol molecules that aremisfolded or defective in Gag–Pol/Gag–Pol inter-
actionmay fail to efﬁciently associate with Pr55gag for virion packaging.
This would explainwhy RT Trp repeatmotif mutations inhibit virion re-
lease as a result of enhanced Gag cleavage, or impair both Gag proces-
sing and Gag–Pol packaging. Protein–protein interactions mediated by
tryptophan-rich and proline-rich motifs are well documented (Kay et
al., 2000; Simon et al., 1998). Tolerance to phenylalanine substitutions
atW401 andW402 suggests aromatic amino acid retention at positions
considered central to the roles of the Trp repeat motif. Trp, Phe, and Tyr
side chains have been proposed as favoring intra- and inter-peptide
electrostatic interactions that contribute to protein secondary structure
and stabilize protein–protein interaction (Dougherty, 2007). Thus, the
HIV-1 RT Trp repeat motif may support the maintenance of stable
Gag–Pol conformation, thereby also supporting necessary Gag–Pol/
Gag–Pol interaction for triggering PR activation.
Mutations at the RT primer grip (L234A) or thumb subdomain
(L289K) also resulted in RT instability associated with reduced sensitiv-
ity to the EFV enhancement effect (Figs. 1 and 2), similar to observations
for some of the mutations at the Trp repeat motif; this suggests the in-
volvement of L234 and L289 in Gag–Pol/Gag–Pol interaction. Accord-
ingly, in addition to the RT connection subdomain, the other RT
subdomains in the Gag–Pol context may contribute to virus maturation
and Gag–Pol packaging by favoring stable Gag–Pol folding or Gag–Pol/
Gag–Pol interaction. Furthermore, these domains may help stabilize
the p66/51RT heterodimer during the post-assembly and post-
processing stages, suggesting that these RT regions have therapeutic
target potential as part of a larger anti-HIV strategy.
Fig. 5. Effect of RT mutations on Gag–Pol packaging. 293 T cells were (A) transfected with wt or mutant HIVgpt plasmids containing the designated double or triple substitution
mutations, or a deletion of the Trp repeat motif (ΔTRM). At 4 h post-transfection, cells were rinsed with PBS and refed with medium containing 5 μM of HIV-1 protease inhibitor
(PI) Ro31-8959 to completely block PR activity. At 48 h post-transfection, supernatants were collected and ﬁltered through a 20% sucrose cushion as described in Materials and
methods. Viral pellets and cell lysates were subjected to Western immunoblot analysis. (B) Virus-associated Pr160gag–pol and Pr55gag levels were quantiﬁed by scanning Pr160gag–pol
and Pr55gag band densities from immunoblots. Ratios of Pr160gag–pol to Pr55gag were determined for each mutant and normalized to those of wt in parallel experiments. Values
were derived from four independent experiments. Bars indicate standard deviation. **pb0.01. (C) 293 T cells were transfectedwith PR-defective (PR-) versions of the designated
constructs (left panel), or co-transfected with a Pr55gag expression vector (pGAG) plus a designated construct containing Gag–Pol frameshift (GPfs) and PR-inactivated (PR-)
mutations (right panel). At 48 h post-transfection, culture supernatants were collected, prepared, and subjected to Western immunoblot analyses. Samples were undiluted
or diluted two-fold and loaded in parallel. Blots in upper panel were intentionally overexposed to allow for visualization of the Pr160gag–pol bands. Pr160gag–pol and Pr55gag
(lower panel) band densities were quantiﬁed; Pr160gag–pol-to-Pr55gag ratios for individual mutants were normalized to those of wt in parallel experiments.
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Plasmid construction
The parental HIV-1 proviral sequence in this study is HXB2 (Ratner
et al., 1985). All constructs for expressing Gag and Gag–Pol were derived
from a replication-defective HIV-1 expression vector, HIVgpt (Page
et al., 1990). DNA fragments containing the engineered RTmutations
were generated by PCR-based overlap extension mutagenesis using
HIVgpt as template. Primers (forward) for RT mutation construction
are as follows: W398A, 5′-CAAAAGGAAACAGCTGAAACA-3′; W401L,
5′-TGGGAAACACTGTGGACAGAGTAT-3′; W401F, 5′-TGGGAAACGTT
CTGGACAGAGTAT-3′; Y405A, 5′-TGGTGGACAGAGGCCTGGCAA-3′;
W406A, 5′-TGGTGGACCGAATATGCGCAAGCC-3′; W410A, 5′-GCCACCGC
GATTCCTGAGTGGGAATTTGTT-3′; W414A, 5′-ATTCCTGAGGCCGAATTTG
TT-3′; W414L, 5′-ATTCCTGAGTTAGAATTTGTT-3′; W398/401A, 5′-AAG
GAAACAGCTGAAACAGCTTGGACAGAG-3′; L289K, 5′-CCTTAGAGGTACCA
AAGCAAAAACAGAAGTA-3′.
The reverse primer is 5′-GAAATTGGATCCATTGGCAGTATGTATTG-3′.For constructing L234A, primers are 5′-AGGCTGTACAGTCCATT
TATCAGGATGGGCTTCATAACC-3 (reverse) and 5′-GGA TTAGATATCA
GTACAATG-3′ (forward). Primers for creating ΔTRM are 5′-CCCATACAA
AAGGAAACAGAGTTTGT-3′ (forward) and 5′-TCCTTTGTCTCAAACAATTG
TGGGGA-3′ (reverse).
Resulting amplicons served as primers for a second PCR round
using either the forward primers 5′-AATGATGCAGAGAGGCAAT-3′ or
5′-GGATTAGATATCAGTACAATG-3, or the reverse primer 5′-
GAAATTGGATCCATTGGCAGTATGTATTG-3′. Ampliﬁed DNA fragments
were digested with a combination of EcoRV and BsrGI and ligated into
HIVgpt. Mutants L100I/K103N, W401A andW401/402A (Chiang et al.,
2009), and W402A (Chiang et al., 2010) have been described in detail
previously. Each of cloned constructs will be analyzed by restriction
enzyme digestion and conﬁrmed by DNA sequencing.
Cell culture and transfection
293 T or HeLa cells were maintained in DMEM supplemented with
10% fetal calf serum. Conﬂuent 293 T cells were trypsinized, split 1:10
Fig. 6. RT Trp repeat motif mutations signiﬁcantly affected Gag cleavage efﬁciency.
293 T cells were transfected with wt or mutant HIVgpt plasmids. At 4 h post-
transfection, cells were split equally and placed onto three dish plates. Cells were col-
lected at 16, 24, and 48 h post-transfection and subjected to Western immunoblot an-
alyses. Cellular Pr55gag and p24gag levels were quantiﬁed by scanning Pr55gag and
p24gag band densities from immunoblots. Ratios of p24gag to p55gag were determined
for each mutant and normalized to those of wt in parallel experiments. Values were de-
rived from three independent experiments. Bars indicate standard deviation. *pb0.05;
**pb0.01.
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struct, 293 T cells were transfected with 20 μg of plasmid DNA by the
calcium phosphate precipitation method (Graham and van der Eb,
1973), with the addition of 50 μM chloroquine to enhance transfec-
tion efﬁciency. Culture media and cells were harvested for protein
analysis at 48 h posttransfection.
Single-cycle infection assays
For infections, 10 μg of each of the mutant HIVgpt plus 5 μg of the
VSV- G protein expression plasmid pHCMV-G (Yee et al., 1994) were
cotransfected into 293 T cells. At 48 h after transfection, virus-
containing supernatants were collected, ﬁltered and used to infect
HeLa cells. Adsorption of virions was allowed to proceed in thepresence of 4 μg/ml polybrene. Selected mycophenolic acid resistant
colonies were ﬁxed and stained with 50% methanol containing 0.5%
methylene blue. Numbers of drug-resistant colonies were converted
into titers (cfu/ml). Infectivity is expressed as the ratio of the mutant
titer to the titer of wt in parallel experiments.
In vitro RT assay
The procedure used for this study has been described previously
(Chiu et al., 2002). Brieﬂy, transfected 293 T cell culture supernatant
was harvested, ﬁltered, and pelleted as described for our Western im-
munoblot analysis. After serially diluting viral pellets suspended in
TSE, 10 μl of diluted sample was mixed with 40 μl of reaction cocktail
containing 0.1% Triton X-100, 5 mM dithiothreitol, 10 mM MgCl2,
50 mM Tris–HCl (pH 8.0), 1.2 mM poly(rA)-(dT)15 (Invitrogen), and
25 μCi of [3H]TTP per ml. Reaction mixtures were incubated at 37 °C
for 2 h, followed by the addition of 5 μl tRNA (10 mg/ml). Reaction
mixtures were precipitated with ice-cold 10% trichloroacetic acid
and ﬁltered through CF/C ﬁlters. After washing and drying, RT activity
was determined using a Beckman scintillation counter.
Velocity sedimentation
Cells were rinsed twice with PBS, pelleted, resuspended in 1 ml
TSE buffer containing Complete protease inhibitor cocktail and ho-
mogenized by sonication. Cell lysates were centrifuged at 3,000 rpm
for 20 min at 4 °C, after which 500 μl of postnuclear supernatant
was mixed with an equal amount of TSE buffer and applied to the
top of a 25–45% discontinuous sucrose gradient. The gradient was
prepared in TSE buffer containing 1 ml each of 25%, 35%, and 45% su-
crose or 1 ml of each of 20%, 30%, 40%, 50%, and 60% sucrose and cen-
trifuged at 130,000×g for 1 h at 4 °C. Four or ﬁve 1 ml fractions were
collected from the top of each centrifuge tube. Proteins present in the
aliquots of each fraction were precipitated with 10% TCA and sub-
jected to Western blot analysis as described previously (Chang et
al., 2007).
Western immunoblot analysis
Culture media from transfected 293 T cells were ﬁltered (0.45-μm
pores) and centrifuged through 2 ml 20% sucrose in TSE (10 mM Tris–
HCl, pH 7.5, 100 mM NaCl, 1 mM EDTA) containing 0.1 mM phenyl-
methylsulfonyl ﬂuoride (PMSF) at 4 °C for 40 min at 274,000×g
(SW41 rotor at 40,000 rpm). Viral pellets and cell lysates mixed
with sample buffer were subjected to SDS-10% PAGE followed by im-
munoblotting analysis as previously described (Chiang et al., 2009).
HIV-1 Gag proteins were probed with an anti-p24gag monoclonal an-
tibody (mouse hybridoma clone 183-H12-5C) at a dilution of 1:5000
from ascites.
For HIV-1 RT detection, the primary antibody was rabbit antise-
rum or a mouse anti-RT monoclonal antibody (Ferris et al., 1990;
Hizi et al., 1988). Rabbit antiserum served as the primary antibody
for HIV-1 IN detection (Grandgenett and Goodarzi, 1994). Cellular
β-actin was detected using a mouse anti-β-actin monoclonal anti-
body (Sigma). The secondary antibody is a sheep anti-mouse or a
donkey anti-rabbit (HRP)-conjugated antibody and the procedures
used for HRP activity detection followed the manufacturer's protocol
(PerkinElmer).
Electron microscopy
Virus-containing supernatants were centrifuged through 20% su-
crose cushion. Concentrated viral sample was placed for 2 min onto
a carbon-coated, UV-treated 200 mesh copper grid as described
(Liao et al., 2007). Sample-containing grids were rinsed 15 s in
water, drained off water with ﬁlter paper, and stained for 1 min in
286 C.-C. Chiang et al. / Virology 422 (2012) 278–287ﬁltered 1.3% uranyl acetate. Staining solution was drained off by ap-
plying ﬁlter paper to the edge of the grid. Grids were left to dry before
viewing in a JOEL JEM-2000 EXII transmission electron microscope.
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